Acute Ischemic Stroke Trial - Oral Aspirin vs Intravenous Heparin on Stroke Progression "AIST"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

Patients who presented within 48 hours of ischemic stroke were eligible for the study.

Exclusion Criteria

Patients with cardioembolic stroke, transient ischemic attacks (TIA), large infarcts requiring intracranial pressure control, severe strokes (e.g. basilar occlusion), internal bleeding, or strokes requiring thrombolytic therapy were excluded from the study.